A child arrives for an eye examination because school boards appear blurry. For decades, the standard approach involved measuring refractive error, prescribing glasses, and restoring clear vision. Today, that same visit serves a broader purpose: it can identify when myopia first appeared, track its progression rate, and assess whether a child’s long-term eye health faces greater risk.
This change reflects a deeper understanding of myopia. It is no longer treated solely as a vision correction issue but recognized as a chronic ocular health concern requiring early intervention and ongoing management. Evidence supporting this approach has grown, especially in regions where myopia prevalence has surged in recent years, including the Middle East.
Myopia is no longer confined to East Asia
Worldwide estimates indicate that 22.9% of the global population was myopic in 2000, with projections reaching 49.8% by 2050. High myopia is expected to rise from 2.7% to 9.8% over the same period. While East Asia has dominated discussions due to its high rates, data from the Middle East and Africa reveal the problem is expanding globally.
In Saudi Arabia, a study of 3,678 schoolchildren in Taif found 33.2% of examined eyes were myopic, with prevalence increasing from 26.8% in children aged 7–9 to 43.8% in those aged 16–18. A more recent study in Jordan, involving 542 children in Amman, identified myopia in 11% of participants, rising from 8% in six-year-olds to 18% in 15-year-olds. These figures vary by methodology and location but confirm a clear trend: myopia is spreading beyond high-prevalence markets in Asia.
A systematic review of 42 studies across 19 African countries, covering over 737,000 children, found myopia prevalence in studies conducted between 2011 and 2021 was roughly double that of studies from 2000 to 2010. The increase is consistent, though the pace differs across populations. The key takeaway is that myopia is no longer a distant concern—it is present and growing.
Each additional diopter of myopia heightens the risk of serious eye conditions. Research links higher myopia to a 58% greater risk of myopic maculopathy, a 30% higher chance of retinal detachment, and a 20% increased likelihood of open-angle glaucoma. The objective is not to eliminate myopia entirely, an unattainable goal, but to slow its progression, which can significantly reduce long-term risks.
Earlier onset increases risk, and demands earlier action
A child who develops myopia at a younger age has more years for progression than one who starts at an older age. A study of 928 myopic children in Singapore found younger age of onset was the strongest predictor of high myopia later in childhood. Annual cycloplegic refraction and axial length measurements confirmed that earlier intervention could alter the condition’s trajectory.
A prescription informs parents about a child’s current vision but does not predict future progression. Tracking refraction over time, assessing axial length where possible, and applying evidence-based interventions to slow progression are now essential. The traditional approach was reactive, glasses were prescribed when vision blurred, with follow-ups only when symptoms returned. The new model is proactive.
The International Myopia Institute clarified key terms in myopia care. Myopia correction addresses refractive error to restore clear distance vision without targeting progression. Myopia control uses interventions to slow axial elongation. Myopia management is broader, encompassing prevention, risk assessment, early detection, lifestyle guidance, and long-term monitoring.
The focus for clinicians has shifted from how to correct a child’s vision to how to manage myopia over time. This requires continuity of care, as a child may see multiple providers over the years, and records must follow them. Parents need to understand why follow-up is necessary even when current corrections work. Schools, pediatricians, and family doctors can raise awareness but cannot replace specialized eye care.
The region now faces the challenge of translating awareness into action. In the Middle East, professional education, parent understanding, and clearer referral pathways are critical. The evidence shows that earlier identification and proactive management make a difference, and the region cannot afford to wait for prevalence to match East Asia’s levels before acting.
Leave a Reply